L
Lite Strategy
LITSClinical-stage pharmaceutical company(NASDAQ: LITS)
Market Performance
Tokenized Assets
| Ticker | Exchange | Price | 24H | Spread | Liquidity ±2% | 24H Volume | OI | Funding | Max Leverage | Fees |
|---|
Clinical-stage pharmaceutical company(NASDAQ: LITS)
| Ticker | Exchange | Price | 24H | Spread | Liquidity ±2% | 24H Volume | OI | Funding | Max Leverage | Fees |
|---|